Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol

• Published in: Neurotoxicology (Park Forest South) Vol. 44; pp. 160 - 168
• Main Authors: Park, Sun Young, Kim, Do Yeon, Kang, Jong-koo, Park, Geuntae, Choi, Young-Whan
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2014
• Subjects: 6-OHDA; Antioxidant Response Elements; Apoptosis; Apoptosis - drug effects; Cell Line, Tumor; CREB; Dopaminergic Neurons - drug effects; Dopaminergic Neurons - metabolism; Humans; Neuroblastoma; Neuroprotective Agents - pharmacology; NF-E2-Related Factor 2 - metabolism; Oxidative stress; Oxidopamine - toxicity; Reactive Oxygen Species - metabolism; Schisandra; Sesquiterpenes - pharmacology; Signal Transduction - drug effects; α-iso-cubebenol; α-iso-cubebenol; Oxidative stress; 6-OHDA; CREB; Apoptosis
• ISSN: 0161-813X; 1872-9711
• DOI: 10.1016/j.neuro.2014.06.011

•α-iso-cubebenol protects SH-SY5Y against 6-OHDA-induced cell death.•α-iso-cubebenol activates PKA and PKB in SH-SY5Y cells.•α-iso-cubebenol activates CREB and Nrf2 in SH-SY5Y cells.•α-iso-cubebenol induces HO-1 and NQO1 in SH-SY5Y cells.•The neuroprotective effects of α-iso-cubebenol involve the CREB and Nrf2 pathways. Free radical-mediated neurodegeneration is one of the many causes of Parkinson's disease (PD). As part of our ongoing studies on the identification of biologically active Schisandra chinensis components, we have isolated and structurally elucidated α-iso-cubebenol. This study was carried out in an attempt to clarify the neuroprotective effect of α-iso-cubebenol on toxin-insulted dopaminergic neuronal death using 6-hydroxy-dopamine (6-OHDA)-induced dopaminergic SH-SY5Y cells. α-iso-cubebenol significantly attenuated the loss of mitochondrial function (MTT assay) and membrane integrity (lactate dehydrogenase assay) associated with 6-OHDA-induced neurotoxicity. Pretreatment of the cells with α-iso-cubebenol diminished the intracellular accumulation of reactive oxygen species (ROS) and calcium in response to 6-OHDA. Moreover, α-iso-cubebenol protected against 6-OHDA-induced neurotoxicity through inhibition of SH-SY5Y cell apoptosis. In addition, JC-1 staining, which is a well-established measure of mitochondrial damage, was decreased after treatment with α-iso-cubebenol. Notably, α-iso-cubebenol inhibited the release of mitochondrial flavoprotein apoptosis inducing factor (AIF) from the mitochondria to the cytosol and nucleus following 6-OHDA treatment. In addition, α-iso-cubebenol reduced the 6-OHDA-induced phosphorylation of ERK and induced the phosphorylation of PKA, PKB, and CREB in a dose-dependent manner. Moreover, α-iso-cubebenol stimulated the activation of Nrf2, a downstream target of CREB. Furthermore, α-iso-cubebenol stimulated the expression of multiple antioxidant response genes (NQO-1 and HO-1). Finally, CREB and Nrf2 siRNA transfection diminished α-iso-cubebenol-mediated neuroprotection.